Bright Minds Biosciences Inc banner
B

Bright Minds Biosciences Inc
NASDAQ:DRUG

Watchlist Manager
Bright Minds Biosciences Inc
NASDAQ:DRUG
Watchlist
Price: 88.68 USD -1.63%
Market Cap: $395.8m
No Transactions Found

We don't have any information about DRUG's insider trading.

Global
Insiders Monitor

Bright Minds Biosciences Inc
Glance View

Market Cap
395.8m USD
Industry
Biotechnology

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in developing therapeutics to improve the lives of patients with severe and life-altering diseases. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-02-08. The firm is focused on developing transformative treatments for neuropsychiatric disorders, epilepsy and pain. The firm has a portfolio of serotonin agonists designed to target neurocircuit abnormalities to treat disorders, such as resistant epilepsy, treatment resistant depression, post-traumatic stress disorder (PTSD), and pain. The company is focused on developing a line of serotonergic 5-Hydroxytryptamine (5-HT) drug candidates that target the 5-HT2C, 5-HT2A and 5-HT2A + 5-HT2C receptors. Its offers 5-HT2C for the treatment of dravet syndrome and behavioral disorders. Its offers 5-HT2A for treatment of depression and other neuropsychiatric disorders. Its offers 5-HT2A + 5-HT2C for several chronic pain disorders/neuropathic pain syndromes, including cluster headaches and chemotherapy-induced peripheral neuropathy.

DRUG Intrinsic Value
7.62 USD
Overvaluation 91%
Intrinsic Value
Price $88.68
B

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett